Loading...

Centric Health

DB:29C
Snowflake Description

Mediocre balance sheet with concerning outlook.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
29C
DB
CA$53M
Market Cap
  1. Home
  2. DE
  3. Consumer Retailing
Company description

Centric Health Corporation provides healthcare services to patients and customers in Canada. The last earnings update was 28 days ago. More info.


Add to Portfolio Compare Print
  • Centric Health has significant price volatility in the past 3 months.
29C Share Price and Events
7 Day Returns
-3.6%
DB:29C
-0.3%
Europe Consumer Retailing
1%
DE Market
1 Year Returns
-36.8%
DB:29C
1.3%
Europe Consumer Retailing
-5.6%
DE Market
29C Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Centric Health (29C) -3.6% -1.6% -16% -36.8% 17.2% 17.2%
Europe Consumer Retailing -0.3% -0.3% 0.3% 1.3% -2.8% -9.4%
DE Market 1% 6.1% 8.4% -5.6% 10.9% 13.8%
1 Year Return vs Industry and Market
  • 29C underperformed the Consumer Retailing industry which returned 1.3% over the past year.
  • 29C underperformed the Market in Germany which returned -5.6% over the past year.
Price Volatility
29C
Industry
5yr Volatility vs Market

Value

 Is Centric Health undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Centric Health to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Centric Health.

DB:29C Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 2 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 6.3%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:29C
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 6%
Consumer Retailing Unlevered Beta Simply Wall St/ S&P Global 0.46
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.464 (1 + (1- 26.5%) (163.5%))
1.015
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.01
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (1.015 * 5.96%)
6.28%

Discounted Cash Flow Calculation for DB:29C using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Centric Health is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

DB:29C DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (CAD, Millions) Source Present Value
Discounted (@ 6.28%)
2019 0.05 Est @ -97.4% 0.05
2020 0.02 Est @ -68.11% 0.02
2021 0.01 Est @ -47.61% 0.01
2022 0.01 Est @ -33.26% 0.00
2023 0.00 Est @ -23.21% 0.00
2024 0.00 Est @ -16.18% 0.00
2025 0.00 Est @ -11.26% 0.00
2026 0.00 Est @ -7.81% 0.00
2027 0.00 Est @ -5.4% 0.00
2028 0.00 Est @ -3.71% 0.00
Present value of next 10 years cash flows CA$0.09
DB:29C DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= CA$0.00 × (1 + 0.23%) ÷ (6.28% – 0.23%)
CA$0.05
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= CA$0.05 ÷ (1 + 6.28%)10
CA$0.03
DB:29C Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= CA$0.09 + CA$0.03
CA$0.12
Equity Value per Share
(CAD)
= Total value / Shares Outstanding
= CA$0.12 / 210.55
CA$0
DB:29C Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:29C represents 0.736x of TSX:CHH
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.736x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (CAD) x Listing Adjustment Factor
= CA$ 0.00 x 0.736
€0.00
Value per share (EUR) From above. €0.00
Current discount Discount to share price of €0.18
= -1 x (€0.18 - €0.00) / €0.00
-44420.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Centric Health is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Centric Health's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Centric Health's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:29C PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in CAD CA$-0.17
TSX:CHH Share Price ** TSX (2019-04-24) in CAD CA$0.25
Europe Consumer Retailing Industry PE Ratio Median Figure of 32 Publicly-Listed Consumer Retailing Companies 19.33x
Germany Market PE Ratio Median Figure of 424 Publicly-Listed Companies 19.72x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Centric Health.

DB:29C PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSX:CHH Share Price ÷ EPS (both in CAD)

= 0.25 ÷ -0.17

-1.48x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Centric Health is loss making, we can't compare its value to the Europe Consumer Retailing industry average.
  • Centric Health is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Centric Health's expected growth come at a high price?
Raw Data
DB:29C PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.48x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts
Not available
Europe Consumer Retailing Industry PEG Ratio Median Figure of 24 Publicly-Listed Consumer Retailing Companies 1.52x
Germany Market PEG Ratio Median Figure of 269 Publicly-Listed Companies 1.58x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Centric Health, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Centric Health's assets?
Raw Data
DB:29C PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in CAD CA$-0.04
TSX:CHH Share Price * TSX (2019-04-24) in CAD CA$0.25
Europe Consumer Retailing Industry PB Ratio Median Figure of 41 Publicly-Listed Consumer Retailing Companies 1.55x
Germany Market PB Ratio Median Figure of 574 Publicly-Listed Companies 1.87x
DB:29C PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSX:CHH Share Price ÷ Book Value per Share (both in CAD)

= 0.25 ÷ -0.04

-6.71x

* Primary Listing of Centric Health.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Centric Health has negative assets, we can't compare the value of its assets to the Europe Consumer Retailing industry average.
X
Value checks
We assess Centric Health's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Consumer Retailing industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Consumer Retailing industry average (and greater than 0)? (1 check)
  5. Centric Health has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Centric Health expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
17.7%
Expected annual growth in revenue.
Earnings growth vs Low Risk Savings
Is Centric Health expected to grow at an attractive rate?
  • Unable to compare Centric Health's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Centric Health's earnings growth to the Germany market average as no estimate data is available.
  • Centric Health's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:29C Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:29C Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 2 Analysts 17.7%
Europe Consumer Retailing Industry Earnings Growth Rate Market Cap Weighted Average 12%
Europe Consumer Retailing Industry Revenue Growth Rate Market Cap Weighted Average 3.8%
Germany Market Earnings Growth Rate Market Cap Weighted Average 11.6%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:29C Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:29C Future Estimates Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 211 1
2020-12-31 171 2
2019-12-31 130 1
DB:29C Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2018-12-31 124 7 -34
2018-09-30 171 14 -20
2018-06-30 170 12 -19
2018-03-31 170 15 1
2017-12-31 122 16 -4
2017-09-30 168 14 -6
2017-06-30 170 24 -3
2017-03-31 170 10 -13
2016-12-31 167 2 -18
2016-09-30 166 6 -21
2016-06-30 166 3 -34
2016-03-31 164 20 -30

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Centric Health is high growth as no earnings estimate data is available.
  • Centric Health's revenue is expected to grow by 17.7% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:29C Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below

All data from Centric Health Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:29C Future Estimates Data
Date (Data in CAD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31
2020-12-31
2019-12-31
DB:29C Past Financials Data
Date (Data in CAD Millions) EPS *
2018-12-31 -0.17
2018-09-30 -0.10
2018-06-30 -0.09
2018-03-31 0.01
2017-12-31 -0.02
2017-09-30 -0.03
2017-06-30 -0.01
2017-03-31 -0.08
2016-12-31 -0.11
2016-09-30 -0.13
2016-06-30 -0.21
2016-03-31 -0.19

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Centric Health will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Centric Health's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Centric Health has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Centric Health performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Centric Health's growth in the last year to its industry (Consumer Retailing).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Centric Health does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare Centric Health's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Centric Health's 1-year growth to the Europe Consumer Retailing industry average as it is not currently profitable.
Earnings and Revenue History
Centric Health's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Centric Health Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:29C Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 123.74 -34.39 41.67
2018-09-30 170.82 -19.95 55.51
2018-06-30 170.49 -18.66 54.92
2018-03-31 169.88 1.23 54.37
2017-12-31 122.01 -4.38 38.24
2017-09-30 168.12 -5.68 54.72
2017-06-30 169.90 -2.52 56.48
2017-03-31 170.23 -13.25 58.45
2016-12-31 167.36 -18.15 59.45
2016-09-30 165.77 -21.17 64.43
2016-06-30 165.75 -34.06 65.62
2016-03-31 164.37 -30.46 66.57
2015-12-31 160.75 -35.26 67.19
2015-09-30 26.89 -47.09 13.16
2015-06-30 60.29 -47.90 26.79
2015-03-31 97.47 -48.96 41.30
2014-12-31 135.21 -43.88 55.34
2014-09-30 301.43 -48.03 119.59
2014-06-30 295.10 -43.10 118.56
2014-03-31 289.03 -49.08 119.49
2013-12-31 281.15 -38.64 119.32
2013-09-30 319.48 -56.83 153.06
2013-06-30 357.87 -57.76 176.00
2013-03-31 399.33 -0.62 196.45
2012-12-31 436.65 -7.26 213.44
2012-09-30 403.00 -21.23 227.49
2012-06-30 362.74 24.01 178.67

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Centric Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
  • It is difficult to establish if Centric Health has efficiently used its assets last year compared to the Europe Consumer Retailing industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Centric Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Centric Health's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Consumer Retailing industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Centric Health has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Centric Health's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Centric Health's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Centric Health's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Centric Health's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Centric Health's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Centric Health has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Centric Health Company Filings, last reported 3 months ago.

DB:29C Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 -7.65 86.07
2018-09-30 -2.03 82.59
2018-06-30 -1.21 81.76
2018-03-31 19.08 84.97
2017-12-31 20.13 81.43
2017-09-30 15.71 81.87
2017-06-30 16.43 80.56 3.10
2017-03-31 13.37 85.54
2016-12-31 2.95 95.88
2016-09-30 0.30 86.49 4.78
2016-06-30 -4.46 88.97 4.28
2016-03-31 5.37 86.76 10.87
2015-12-31 14.95 307.55 14.88
2015-09-30 -55.54 294.53 2.18
2015-06-30 -50.81 298.43 2.45
2015-03-31 -43.91 299.07 7.36
2014-12-31 -34.01 291.55 0.24
2014-09-30 -26.29 290.22 6.60
2014-06-30 -27.94 304.00
2014-03-31 -12.73 298.90 1.21
2013-12-31 14.91 296.08
2013-09-30 56.06 288.35
2013-06-30 94.68 288.76
2013-03-31 103.41 281.08 0.12
2012-12-31 95.11 271.68 0.59
2012-09-30 130.61 276.24 1.09
2012-06-30 131.85 283.80 3.50
  • Centric Health has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
  • Irrelevant to check if Centric Health's debt level has increased considering it has negative shareholder equity.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Whilst loss making Centric Health has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
  • Whilst loss making Centric Health has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 29.5% per year.
X
Financial health checks
We assess Centric Health's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Centric Health has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Centric Health's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Centric Health dividends.
If you bought €2,000 of Centric Health shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Centric Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Centric Health's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:29C Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
Europe Consumer Retailing Industry Average Dividend Yield Market Cap Weighted Average of 34 Stocks 3.7%
Germany Market Average Dividend Yield Market Cap Weighted Average of 327 Stocks 3%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.4%
Germany Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:29C Future Dividends Estimate Data
Date (Data in CA$) Dividend per Share (annual) Avg. No. Analysts
2021-12-31
2020-12-31
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Centric Health has not reported any payouts.
  • Unable to verify if Centric Health's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Centric Health's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Centric Health has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Centric Health's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Centric Health afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Centric Health has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Centric Health's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
David Murphy
TENURE AS CEO 0.9 years
CEO Bio

Mr. David Murphy has been the President at Cardinal Health Canada Inc. since April 2016. He has been the President and Chief Executive Officer at Centric Health Corporation since May 1, 2018. He has been an Additional Director at Centric Health Corporation since May 9, 2018. Before joining Cardinal Health, Mr. Murphy spent ten years with Stryker, serving as President of their Canadian business. For three years, he also had leadership responsibility for Stryker’s business in Latin America. He held executive positions in the consumer products industry. Mr. Murphy serves as the President and Chief Executive Officer at Centric Health Corporation. Mr. Murphy holds a Bachelor of Arts degree from McMaster University and a law degree and MBA from the University of Toronto.

CEO Compensation
  • Insufficient data for David to compare compensation growth.
  • Insufficient data for David to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team Tenure

Average tenure of the Centric Health management team in years:

1.3
Average Tenure
  • The average tenure for the Centric Health management team is less than 2 years, this suggests a new team.
Management Team

Ryan Stempfle

TITLE
VP & GM of Western Canada for the Specialty Pharmacy Division
COMPENSATION
CA$176K
TENURE
2.3 yrs

David Murphy

TITLE
President
TENURE
0.9 yrs

Andrew Mok

TITLE
Interim Chief Financial Officer
TENURE
0.4 yrs

Paul Rakowski

TITLE
VP, General Counsel & Corporate Secretary
TENURE
1.6 yrs

Nina Freier

TITLE
Chief Human Resources Officer
TENURE
0.5 yrs

Harold Becker

TITLE
Head of Catastrophic Injury Assessment Field
TENURE
13 yrs
Board of Directors Tenure

Average tenure and age of the Centric Health board of directors in years:

3.7
Average Tenure
63
Average Age
  • The tenure for the Centric Health board of directors is about average.
Board of Directors

Kevin Dalton

TITLE
Chairman of the Board
COMPENSATION
CA$119K
TENURE
0.8 yrs

David Murphy

TITLE
President
TENURE
0.9 yrs

Jack Shevel

TITLE
Chairman Emeritus
COMPENSATION
CA$146K
AGE
61
TENURE
0.8 yrs

Yazdi Bharucha

TITLE
Independent Non-Executive Director
COMPENSATION
CA$102K
AGE
69
TENURE
6.2 yrs

Robert M. Hollinshead

TITLE
Independent Director
COMPENSATION
CA$101K
TENURE
4.3 yrs

Rik Ganderton

TITLE
Independent Director
COMPENSATION
CA$94K
TENURE
3.7 yrs

Darren Youngleson

TITLE
Director
COMPENSATION
CA$83K
AGE
47
TENURE
9.8 yrs

Ingrid Davis

TITLE
Director
COMPENSATION
CA$258K
AGE
65
TENURE
9.2 yrs

John Ewing

TITLE
Additional Independent Director
TENURE
0.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Centric Health's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Centric Health has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Centric Health Corporation provides healthcare services to patients and customers in Canada. It operates through two segments, Specialty Pharmacy, and Surgical and Medical Centres. The Specialty Pharmacy segment provides traditional pharmacy services, such as compounding and dispensing medications, as well as clinical and specialty services for long term care and retirement communities. This segment also provides pharmaceutical dispensing services for employees insured by corporate health plans. The Surgical and Medical Centres segment offers diagnostics services, including MRI/lightspeed 64-slice CT, cardiac CT angiography, colonoscopy, diagnostic ultrasound, digital X-ray, and gastroscopy; and surgical services, such as bariatric/lap band weight loss, general, orthopedic, and plastic surgery, as well as services in the areas of cardiology, dermatology, neurology and neuropathology, otolaryngology, urology, and women’s health and gynecology. This segment also provides specialty programs; offers surgical services, including private paid non-insured surgeries and diagnostics, government outsourcing of insured surgeries and diagnostics, and other procedures funded by third-party payors, as well as owns the Centre of Excellence in Metabolic and Bariatric Surgery; and operates five facilities across four provinces. In addition, the company offers orthotics products and services, such as custom orthotics, knee bracing, laser and shock therapy. The company was formerly known as Alegro Health Corp. and changed its name to Centric Health Corporation in August 2009. Centric Health Corporation was incorporated in 2001 and is headquartered in Toronto, Canada.

Details
Name: Centric Health Corporation
29C
Exchange: DB
Founded: 2001
CA$34,851,534
210,550,854
Website: http://www.centrichealth.ca
Address: Centric Health Corporation
20 Eglinton Avenue West,
Suite 2100,
Toronto,
Ontario, M4R 1K8,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSX CHH Common Shares The Toronto Stock Exchange CA CAD 19. Jun 2003
OTCPK CHHH.F Common Shares Pink Sheets LLC US USD 19. Jun 2003
DB 29C Common Shares Deutsche Boerse AG DE EUR 19. Jun 2003
Number of employees
Current staff
Staff numbers
859
Centric Health employees.
Industry
Drug Retail
Consumer Retailing
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/24 22:25
End of day share price update: 2019/04/24 00:00
Last estimates confirmation: 2019/03/29
Last earnings filing: 2019/03/27
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.